These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 33989898)

  • 1. Elucidating reasons of COVID-19 re-infection and its management strategies.
    Jain VK; Iyengar K; Garg R; Vaishya R
    Diabetes Metab Syndr; 2021; 15(3):1001-1006. PubMed ID: 33989898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating causes of COVID-19 infection and related deaths after vaccination.
    Jain VK; Iyengar KP; Ish P
    Diabetes Metab Syndr; 2021; 15(5):102212. PubMed ID: 34284226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential mortality in COVID-19 patients from India and western countries.
    Jain VK; Iyengar K; Vaish A; Vaishya R
    Diabetes Metab Syndr; 2020; 14(5):1037-1041. PubMed ID: 32640415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India.
    Malhotra S; Mani K; Lodha R; Bakhshi S; Mathur VP; Gupta P; Kedia S; Sankar J; Kumar P; Kumar A; Ahuja V; Sinha S; Guleria R; ; Dua A; Ahmad S; Sathiyamoorthy R; Sharma A; Sakya T; Gaur V; Chaudhary S; Sharma S; Madan D; Gupta A; Virmani S; Gupta A; Yadav N; Sachdeva S; Sharma S; Singh S; Pandey A; Singh M; Jhurani D; Sarkar S; Lokade AK; Mohammad A; Pandit S; Dubey R; Singh AK; Gohar N; Soni D; Bhattacharyya A; Rai S; Tummala S; Gupta I; Shukla S
    JAMA Netw Open; 2022 Jan; 5(1):e2142210. PubMed ID: 34994793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis in the era of COVID-19 in India.
    Jain VK; Iyengar KP; Samy DA; Vaishya R
    Diabetes Metab Syndr; 2020; 14(5):1439-1443. PubMed ID: 32755848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic characteristics of cases with reinfection, recurrence, and hospital readmission due to COVID-19: A systematic review and meta-analysis.
    Sotoodeh Ghorbani S; Taherpour N; Bayat S; Ghajari H; Mohseni P; Hashemi Nazari SS
    J Med Virol; 2022 Jan; 94(1):44-53. PubMed ID: 34411311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic.
    Cohen D; Izak M; Stoyanov E; Mandelboim M; Perlman S; Amir Y; Goren S; Bialik A; Kliker L; Atari N; Yshai R; Zaide Y; Marcus H; Madar-Balakirski N; Israely T; Paran N; Zimhony O; Shinar E; Maor Y; Muhsen K
    Int J Infect Dis; 2023 Jul; 132():72-79. PubMed ID: 37072052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and mortality in doctors.
    Iyengar KP; Ish P; Upadhyaya GK; Malhotra N; Vaishya R; Jain VK
    Diabetes Metab Syndr; 2020; 14(6):1743-1746. PubMed ID: 32920494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on host immunity correlates and prospects of re-infection in COVID-19.
    Negi N; Maurya SP; Singh R; Das BK
    Int Rev Immunol; 2022; 41(4):367-392. PubMed ID: 34961403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study.
    Dhumal S; Patil A; More A; Kamtalwar S; Joshi A; Gokarn A; Mirgh S; Thatikonda P; Bhat P; Murthy V; Chavan P; Oak A; Gore S; Bhattacharjee A; Patkar N; Kannan S; Shetty N; Rawat A; Achrekar M; Trivedi B; Laskar S; Chaturvedi P; Badwe R; Khattry N; Gupta S
    Int J Infect Dis; 2022 May; 118():95-103. PubMed ID: 35192951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 reinfection and implications for vaccine development.
    Nainu F; Abidin RS; Bahar MA; Frediansyah A; Emran TB; Rabaan AA; Dhama K; Harapan H
    Hum Vaccin Immunother; 2020 Dec; 16(12):3061-3073. PubMed ID: 33393854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic.
    Kennedy NA; Janjua M; Chanchlani N; Lin S; Bewshea C; Nice R; McDonald TJ; Auckland C; Harries LW; Davies M; Michell S; Kok KB; Lamb CA; Smith PJ; Hart AL; Pollok RC; Lees CW; Boyton RJ; Altmann DM; Sebastian S; Powell N; Goodhand JR; Ahmad T
    Gut; 2023 Feb; 72(2):295-305. PubMed ID: 35902214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic.
    Guedes AR; Oliveira MS; Tavares BM; Luna-Muschi A; Lazari CDS; Montal AC; de Faria E; Maia FL; Barboza ADS; Leme MD; Tomazini FM; Costa SF; Levin AS
    Sci Rep; 2023 Jan; 13(1):712. PubMed ID: 36639411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine : A Retrospective Cohort Study.
    Gazit S; Shlezinger R; Perez G; Lotan R; Peretz A; Ben-Tov A; Herzel E; Alapi H; Cohen D; Muhsen K; Chodick G; Patalon T
    Ann Intern Med; 2022 May; 175(5):674-681. PubMed ID: 35157493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and clinical characteristics of COVID-19 reinfection during the epidemic period in Yangzhou city, Jiangsu province.
    Wang Y; Liang J; Yang H; Zhu L; Hu J; Xiao L; Huang Y; Dong Y; Wu C; Zhang J; Zhou X
    Front Public Health; 2023; 11():1256768. PubMed ID: 37780420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.
    Malik JA; Ahmed S; Mir A; Shinde M; Bender O; Alshammari F; Ansari M; Anwar S
    J Infect Public Health; 2022 Feb; 15(2):228-240. PubMed ID: 35042059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological assessment of SARS-CoV-2 reinfection.
    Almadhi M; Alsayyad AS; Conroy R; Atkin S; Awadhi AA; Al-Tawfiq JA; AlQahtani M
    Int J Infect Dis; 2022 Oct; 123():9-16. PubMed ID: 35931371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2.
    Sharma R; Sardar S; Mohammad Arshad A; Ata F; Zara S; Munir W
    Am J Case Rep; 2020 Dec; 21():e927154. PubMed ID: 33257644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.
    Nordström P; Ballin M; Nordström A
    Lancet Infect Dis; 2022 Jun; 22(6):781-790. PubMed ID: 35366962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.